A Prospective, Randomized, Trial to Investigate the Effect of Continued Adefovir Versus Combination Regimens of Telbivudine Plus Adefovir, and Telbivudine Plus Tenofovir in Patients With Chronic Hepatitis B and Suboptimal Viral Suppression (PROACTIV Study)
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2015
At a glance
- Drugs Adefovir; Telbivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms PROACTIV Study
- Sponsors Idenix Pharmaceuticals; Novartis
- 11 May 2008 Status changed from initiated to withdrawn prior to recruitment, as reported by ClinicalTrials.gov.
- 11 Jan 2008 Status changed from recruiting to initiated.
- 15 Dec 2006 New trial record.